As breakthroughs in cancer treatment continue to accelerate, understanding their impact on healthcare economics is pivotal. In Europe, novel therapies and diagnostics present significant challenges and opportunities for payors and health systems.
Join this webinar to hear Mansfield Advisors and DeciBio Consulting share their perspective on how emerging technology classes will influence the future of oncology care in Europe and beyond.
Adam Scott, Partner, Mansfield Advisors
Abhishek Patel, Senior Associate, Mansfield Advisors
Henry Elphick, Chair, Mansfield Advisors
Stephane Budel, Co-founder/Partner, DeciBio Consulting
Katie Gillette, Senior Project Manager, DeciBio Consulting